Literature DB >> 33350661

Increased Prevalence of Upper and Lower Respiratory Disease in Operation Enduring Freedom and Operation Iraqi Freedom US Veterans.

Kenric Tam1, Jivianne T Lee.   

Abstract

OBJECTIVE: Veterans of Operation Enduring Freedom and Operation Iraqi Freedom (OEF/OIF) were exposed to high levels of pollutants resulting in increased upper and lower respiratory symptoms and morbidity. The purpose of this study is to determine the physician diagnosed prevalence of upper and lower respiratory disease in OEF/OIF veterans.
METHODS: We queried the Veterans Health Administration Support Service Center database to identify veterans in the Desert Pacific Healthcare Network with International Classification of Diseases 10th Revision diagnoses related to upper respiratory and lower respiratory tract (URT and LRT) diseases and symptoms. Over 100,000 unique veterans were identified.
RESULTS: OEF/OIF veterans had increased prevalence of both sinonasal disease and LRT pathology compared with non-OEF/OIF veterans. In 2016, 8.79% of OEF/OIF veterans demonstrated lower respiratory disease, which was 3.4 times greater than non-OEF/OIF veterans (P < 0.0001). Similarly, upper respiratory disease was 4.8 times more prevalent in OEF/OIF veterans, with 19.28% diagnosed compared with 3.95% of non-OEF/OIF veterans (P < 0.0001).
CONCLUSION: This is the first database study that investigates the prevalence of upper airway disease in OEF/OIF veterans. Veterans serving in the post-9/11 era in Afghanistan and Iraq have a significantly increased prevalence of both lower and upper respiratory disease.
Copyright © 2021 American College of Occupational and Environmental Medicine.

Entities:  

Year:  2021        PMID: 33350661     DOI: 10.1097/JOM.0000000000002114

Source DB:  PubMed          Journal:  J Occup Environ Med        ISSN: 1076-2752            Impact factor:   2.162


  1 in total

1.  In Vitro Effects of Permethrin on Sinonasal Epithelia.

Authors:  Jivianne T Lee; Hong-Ho Yang; Daniel Sanghoon Shin; Eri Srivatsan; Saroj Basak
Journal:  OTO Open       Date:  2022-07-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.